Henry Schein Stock Price, News & Analysis (NASDAQ:HSIC)

$76.41 0.45 (0.59 %)
(As of 01/23/2018 04:57 AM ET)
Previous Close$75.96
Today's Range$75.66 - $76.45
52-Week Range$65.28 - $93.50
Volume1.04 million shs
Average Volume1.56 million shs
Market Capitalization$11.99 billion
P/E Ratio22.02
Dividend YieldN/A
Beta0.99

About Henry Schein (NASDAQ:HSIC)

Henry Schein logoHenry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment Wholesale
Sub-IndustryHealth Care Distributors
SectorHealthcare
SymbolNASDAQ:HSIC
CUSIP80640710
Phone+1-631-8435500

Debt

Debt-to-Equity Ratio0.30%
Current Ratio1.55%
Quick Ratio0.86%

Price-To-Earnings

Trailing P/E Ratio22.0201729106628
Forward P/E Ratio21.23
P/E Growth1.95

Sales & Book Value

Annual Sales$11.57 billion
Price / Sales1.04
Cash Flow$4.44 per share
Price / Cash17.20
Book Value$17.40 per share
Price / Book4.39

Profitability

Trailing EPS$3.47
Net Income$506.77 million
Net Margins4.52%
Return on Equity19.71%
Return on Assets8.09%

Miscellaneous

Employees21,000
Outstanding Shares156,950,000

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were distributed to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, September 19th 2017, which authorizes the company to buyback $400,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 6.3% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board of directors believes its stock is undervalued.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) issued its quarterly earnings results on Monday, November, 6th. The company reported $0.87 EPS for the quarter, missing the Zacks' consensus estimate of $0.90 by $0.03. The business earned $3.16 billion during the quarter, compared to analysts' expectations of $3.05 billion. Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The business's revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.84 earnings per share. View Henry Schein's Earnings History.

When will Henry Schein make its next earnings announcement?

Henry Schein is scheduled to release their next quarterly earnings announcement on Monday, February, 19th 2018. View Earnings Estimates for Henry Schein.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein issued an update on its FY18 earnings guidance on Monday, November, 6th. The company provided EPS guidance of $3.85-3.96 for the period, compared to the Thomson Reuters consensus estimate of $4.01. Henry Schein also updated its FY17 guidance to $3.59-3.61 EPS.

Where is Henry Schein's stock going? Where will Henry Schein's stock price be in 2018?

14 equities research analysts have issued 12-month target prices for Henry Schein's stock. Their forecasts range from $74.00 to $109.00. On average, they anticipate Henry Schein's share price to reach $84.23 in the next twelve months. View Analyst Ratings for Henry Schein.

What are Wall Street analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:

  • 1. According to Zacks Investment Research, "Over the past three months, Henry Schein has underperformed the broader industry. The company witnessing year-over-year deterioration in gross and operating margin due to higher cost of sales and expenses continues to be a concern. This apart, competitive pricing remains another cause of concern. We are disappointed with the company’s lowering of the high end of the 2017 EPS guidance indicating a gloomy scenario ahead. On a positive note, balanced growth across all operating segments as well as the Henry Schein’s gains in the United States as well as overseas raise optimism. We are also positive about the company completing the buyout of Merritt Veterinary Supplies." (1/4/2018)
  • 2. Evercore ISI analysts commented, "HSIC continues to deliver consistent HSD to LDD EPS growth despite an operating environment that has been somewhat mixed, albeit North American Dental continues to show signs of recovery. With the acquisition engine still churning and an elevated level of buybacks, management has been able to deliver the type of TSR expected and thus the valuation remains notably elevated on an absolute basis (less so on a relative basis). While we also value consistency and predictability, we acknowledge we missed the November entry point (fears of US slowdown) and thus at current levels see risk / reward as more fully balanced (particularly with extra week headwind in 2017 + unfavorable Fx environment). Given this dynamic we reiterate our Hold rating and argue shares are now accurately pricing in the current operating environment. Thus we await another period of uncertainty prior to revisiting our long-term constructive view on shares." (2/21/2017)

Who are some of Henry Schein's key competitors?

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:

  • Stanley M. Bergman, Chairman of the Board, Chief Executive Officer (Age 67)
  • James P. Breslawski CPA, President, Director; Chief Executive Officer of Henry Schein Global Dental Group (Age 63)
  • Steven Paladino CPA, Chief Financial Officer, Executive Vice President, Director (Age 60)
  • Peter McCarthy, President of Global Animal Health Group (Age 57)
  • David C. McKinley, President of Corporate Commercial Development Group, Chief Commercial Officer (Age 64)
  • Bob Minowitz, President, International Dental Group, EMEA Region (Age 58)
  • Bridget A. Ross, President of Global Medical Group (Age 52)
  • Gerald A. Benjamin, Chief Administrative Officer, Executive Vice President, Director (Age 64)
  • Mark E. Mlotek, Chief Strategic Officer, Executive Vice President, Director (Age 61)
  • Karen N. Prange, Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group (Age 53)

Who owns Henry Schein stock?

Henry Schein's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include GENERATION INVESTMENT MANAGEMENT LLP (5.10%), GENERATION INVESTMENT MANAGEMENT LLP (5.10%), Schwab Charles Investment Management Inc. (0.37%), Davis R M Inc. (0.31%), Bank of Montreal Can (0.25%) and AMI Asset Management Corp (0.22%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lonnie Shoff, Lorelei Mcglynn, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Paul Rose, Peter M Mccarthy, Philip A Laskawy, Robert Minowitz, Stanley Komaroff and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

Who sold Henry Schein stock? Who is selling Henry Schein stock?

Henry Schein's stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Chevy Chase Trust Holdings Inc., Neville Rodie & Shaw Inc., AMI Asset Management Corp, Montrusco Bolton Investments Inc., Anderson Hoagland & Co., Carroll Financial Associates Inc. and Davis R M Inc.. Company insiders that have sold Henry Schein company stock in the last year include Barry J Alperin, Donald J Kabat, Gerald A Benjamin, James A Harding, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Rose, Philip A Laskawy and Steven Paladino. View Insider Buying and Selling for Henry Schein.

Who bought Henry Schein stock? Who is buying Henry Schein stock?

Henry Schein's stock was acquired by a variety of institutional investors in the last quarter, including DnB Asset Management AS, Bank of Montreal Can, Aurora Investment Counsel, Schwab Charles Investment Management Inc., State of Alaska Department of Revenue, National Pension Service, Bridge Creek Capital Management LLC and Addenda Capital Inc.. View Insider Buying and Selling for Henry Schein.

How do I buy Henry Schein stock?

Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of Henry Schein stock can currently be purchased for approximately $76.41.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $11.99 billion and generates $11.57 billion in revenue each year. The company earns $506.77 million in net income (profit) each year or $3.47 on an earnings per share basis. Henry Schein employs 21,000 workers across the globe.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 Duryea Rd, MELVILLE, NY 11747, United States. The company can be reached via phone at +1-631-8435500 or via email at [email protected]


MarketBeat Community Rating for Henry Schein (HSIC)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  165 (Vote Outperform)
Underperform Votes:  335 (Vote Underperform)
Total Votes:  500
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Henry Schein (NASDAQ:HSIC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.432.402.332.33
Ratings Breakdown: 1 Sell Rating(s)
6 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $84.23$87.79$92.89$90.73
Price Target Upside: 16.76% upside29.92% upside9.89% upside1.61% downside

Henry Schein (NASDAQ:HSIC) Consensus Price Target History

Price Target History for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2018Evercore ISIInitiated CoverageOutperform -> Outperform$81.00MediumView Rating Details
12/27/2017Piper Jaffray CompaniesReiterated RatingBuy$78.00LowView Rating Details
12/8/2017Deutsche BankInitiated CoverageBuy -> Buy$79.00LowView Rating Details
12/6/2017Morgan StanleyDowngradeEqual Weight -> Underweight$88.00HighView Rating Details
11/28/2017Credit Suisse GroupReiterated RatingNeutral$87.50 -> $80.00LowView Rating Details
11/28/2017StephensInitiated CoverageEqual -> Equal Weight$76.00LowView Rating Details
11/7/2017Jefferies GroupLower Price TargetHold$89.00 -> $74.00N/AView Rating Details
11/7/2017Leerink SwannReiterated RatingMarket Perform$87.50 -> $77.00N/AView Rating Details
11/7/2017Stifel NicolausLower Price TargetHold -> Hold$89.00 -> $77.00N/AView Rating Details
11/7/2017Craig HallumUpgradeHold -> BuyN/AView Rating Details
11/7/2017Royal Bank of CanadaLower Price TargetSector Perform -> Sector Perform$91.00 -> $82.00N/AView Rating Details
10/19/2017Robert W. BairdSet Price TargetBuy$95.00N/AView Rating Details
8/7/2017Northcoast ResearchUpgradeNeutral -> Buy$109.00HighView Rating Details
5/10/2017Barrington ResearchBoost Price TargetOutperform -> Outperform$98.00 -> $99.00LowView Rating Details
1/10/2017GabelliUpgradeHold -> Buy$104.00N/AView Rating Details
11/3/2016JPMorgan Chase & Co.Reiterated RatingHold$81.50N/AView Rating Details
10/11/2016Goldman Sachs GroupUpgradeNeutral -> Buy$92.50N/AView Rating Details
9/12/2016Bank of AmericaInitiated CoverageBuy$92.50N/AView Rating Details
(Data available from 1/23/2016 forward)

Earnings

Henry Schein (NASDAQ:HSIC) Earnings History and Estimates Chart

Earnings by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ HSIC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/19/2018$0.97N/AView Earnings Details
11/6/2017Q3 2017$0.90$0.87$3.05 billion$3.16 billionViewN/AView Earnings Details
8/8/2017Q2 17$0.87$0.88$3.05 billion$3.06 billionViewListenView Earnings Details
5/9/2017Q1 17$0.83$0.88$2.83 billion$2.92 billionViewListenView Earnings Details
2/21/2017Q416$0.93$0.94$3.08 billion$3.12 billionViewListenView Earnings Details
11/2/2016Q316$0.83$0.84$2.88 billion$2.87 billionViewN/AView Earnings Details
8/4/2016Q216$0.82$0.82$2.85 billion$2.87 billionViewN/AView Earnings Details
5/3/2016Q116$0.70$0.71$2.66 billion$2.70 billionViewListenView Earnings Details
2/10/2016Q415$0.83$0.84$2.82 billion$2.90 billionViewListenView Earnings Details
11/4/2015Q315$0.74$0.78$2.70 billion$2.70 billionViewListenView Earnings Details
7/29/2015Q215$0.73$0.73$2.68 billion$2.60 billionViewListenView Earnings Details
5/4/2015Q1$0.64$0.64$2.54 billion$25.00 billionViewListenView Earnings Details
2/11/2015Q414$0.76$0.78$2.72 billion$2.70 billionViewListenView Earnings Details
11/6/2014Q314$0.66$0.67$2.55 billion$2.62 billionViewListenView Earnings Details
8/4/2014Q214$0.67$0.68$2.56 billion$2.60 billionViewListenView Earnings Details
5/6/2014Q1$0.57$0.59$2.43 billion$2.40 billionViewListenView Earnings Details
2/11/2014Q413$0.70$0.72$2.53 billion$2.50 billionViewListenView Earnings Details
11/5/2013Q313$0.61$0.61$2.37 billion$2.30 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.62$0.62$2.39 billion$2.40 billionViewListenView Earnings Details
5/7/2013Q1 2013$0.54$0.53$2.25 billion$2.30 billionViewListenView Earnings Details
2/13/2013Q4 2012$0.61$0.63$2.40 billion$2.40 billionViewListenView Earnings Details
11/7/2012Q312$0.54$0.54$2.24 billion$2.23 billionViewN/AView Earnings Details
8/2/2012$0.55$0.56ViewN/AView Earnings Details
5/8/2012$0.46$0.49ViewN/AView Earnings Details
2/15/2012$0.56$0.58ViewN/AView Earnings Details
11/1/2011$0.50$0.50ViewN/AView Earnings Details
8/2/2011$0.50$0.51ViewN/AView Earnings Details
5/3/2011$0.40$0.41ViewN/AView Earnings Details
2/22/2011$0.48$0.50ViewN/AView Earnings Details
10/29/2010Q3 2010$0.44$0.47ViewN/AView Earnings Details
8/2/2010Q2 2010$0.43$0.45ViewN/AView Earnings Details
5/4/2010Q1 2010$0.35$0.37ViewN/AView Earnings Details
2/23/2010Q4 2009$0.46$0.47ViewN/AView Earnings Details
11/4/2009Q3 2009$0.41$0.40ViewN/AView Earnings Details
8/4/2009Q2 2009$0.38$0.41ViewN/AView Earnings Details
5/4/2009Q1 2009$0.29$0.32ViewN/AView Earnings Details
2/24/2009Q4 2008$0.44$0.45ViewN/AView Earnings Details
11/5/2008Q3 2008$0.38$0.39ViewN/AView Earnings Details
8/5/2008Q2 2008$0.34$0.36ViewN/AView Earnings Details
5/6/2008Q1 2008$0.28$0.28ViewN/AView Earnings Details
2/25/2008Q4 2007$0.41$0.42ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Henry Schein (NASDAQ:HSIC) Earnings Estimates

2018 EPS Consensus Estimate: $3.94
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$0.92$1.02$0.95
Q2 20185$0.91$0.97$0.94
Q3 20185$0.85$1.14$0.98
Q4 20185$1.02$1.17$1.06
Q1 20191$1.02$1.02$1.02
Q2 20191$0.96$0.96$0.96
Q3 20191$1.14$1.14$1.14
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Henry Schein (NASDAQ:HSIC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Henry Schein (NASDAQ HSIC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.19%
Institutional Ownership Percentage: 91.75%
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)
Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ HSIC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2017Barry J AlperinDirectorSell5,796$70.76$410,124.9648,172View SEC Filing  
9/6/2017Paul RoseSVPSell2,126$172.51$366,756.2617,841View SEC Filing  
5/11/2017Gerald A BenjaminEVPSell12,578$175.10$2,202,407.8044,061View SEC Filing  
3/23/2017Lorelei McglynnSVPSell9,300$171.76$1,597,368.0033,048View SEC Filing  
3/20/2017Michael RacioppiSVPSell9,969$171.69$1,711,577.6133,057View SEC Filing  
3/17/2017Mark E MlotekEVPSell5,559$170.98$950,477.8240,426View SEC Filing  
3/8/2017James A HardingSVPSell10,552$171.60$1,810,723.2021,118View SEC Filing  
3/8/2017Philip A LaskawyDirectorSell1,103$171.51$189,175.5313,872View SEC Filing  
3/2/2017Michael S EttingerSVPSell6,960$171.09$1,190,786.4031,308View SEC Filing  
2/27/2017Donald J KabatDirectorSell4,334$173.62$752,469.0810,729View SEC Filing  
2/22/2017Paul RoseSVPSell6,821$173.24$1,181,670.0424,674View SEC Filing  
2/22/2017Steven PaladinoCFOSell13,072$173.40$2,266,684.8076,433View SEC Filing  
12/12/2016Kurt P KuehnDirectorBuy1,000$151.41$151,410.002,039View SEC Filing  
11/3/2016Mark E MlotekEVPSell2,417$155.19$375,094.2340,456View SEC Filing  
8/29/2016Paul BronsDirectorSell3,381$164.03$554,585.4313,715View SEC Filing  
6/2/2016Gerald A BenjaminEVPSell9,991$175.08$1,749,224.2854,885View SEC Filing  
5/16/2016James A HardingSVPSell10,302$172.60$1,778,125.2021,933View SEC Filing  
5/12/2016Peter M MccarthyInsiderSell1,158$171.75$198,886.5012,285View SEC Filing  
3/15/2016Lonnie ShoffCEOSell3,028$168.29$509,582.1231,000View SEC Filing  
3/14/2016David MckinleyInsiderSell3,339$167.92$560,684.8827,645View SEC Filing  
3/14/2016Norman S MatthewsDirectorSell5,335$167.75$894,946.2515,425View SEC Filing  
3/10/2016Donald J KabatDirectorSell1,218$168.38$205,086.843,189View SEC Filing  
3/7/2016Barry J AlperinDirectorSell1,635$167.36$273,633.6024,322View SEC Filing  
3/7/2016Michael S EttingerSVPSell5,423$168.13$911,768.9932,286View SEC Filing  
3/4/2016Philip A LaskawyDirectorSell1,317$166.88$219,780.9617,294View SEC Filing  
3/2/2016Louis W SullivanDirectorSell11,735$168.59$1,978,403.6516,830View SEC Filing  
3/2/2016Mark E MlotekEVPSell4,982$167.93$836,627.2645,149View SEC Filing  
2/26/2016Barry J AlperinDirectorSell7,540$167.96$1,266,418.4033,294View SEC Filing  
2/24/2016Robert MinowitzInsiderSell9,648$165.48$1,596,551.0425,788View SEC Filing  
2/22/2016Michael RacioppiSVPSell21,567$166.74$3,596,081.5849,866View SEC Filing  
2/17/2016Stanley KomaroffInsiderSell8,000$163.53$1,308,240.0031,694View SEC Filing  
2/16/2016Norman S MatthewsDirectorSell4,230$160.05$677,011.5017,122View SEC Filing  
2/12/2016Steven PaladinoCFOSell11,727$157.21$1,843,601.6783,602View SEC Filing  
2/11/2016Donald J. KabatDirectorSell6,637$156.36$1,037,761.325,938View SEC Filing  
12/17/2015Michael RacioppiSVPSell9,901$155.92$1,543,763.9228,299View SEC Filing  
12/10/2015Stanley M. BergmanCEOSell61,800$155.45$9,606,810.00152,926View SEC Filing  
11/9/2015Paul RoseSVPSell3,638$151.92$552,684.9619,223View SEC Filing  
11/5/2015Mark E. MlotekEVPSell2,952$155.00$457,560.0046,116View SEC Filing  
11/5/2015Stanley KomaroffInsiderSell6,297$154.89$975,342.3339,694View SEC Filing  
9/16/2015Philip A LaskawyDirectorSell4,000$136.20$544,800.0016,191View SEC Filing  
5/6/2015Paul BronsDirectorSell3,801$136.70$519,596.70View SEC Filing  
3/19/2015Michael S EttingerSVPSell4,352$139.75$608,192.00View SEC Filing  
3/18/2015James P BreslawskiCEOSell12,811$139.45$1,786,493.95View SEC Filing  
3/17/2015Leonard A DavidSVPSell3,935$140.00$550,900.00View SEC Filing  
3/16/2015Paul RoseSVPSell3,264$140.13$457,384.32View SEC Filing  
3/13/2015Norman S MatthewsDirectorSell9,200$136.07$1,251,844.00View SEC Filing  
3/11/2015Philip A LaskawyDirectorSell2,669$136.60$364,585.40View SEC Filing  
3/10/2015Donald J KabatDirectorSell2,002$138.00$276,276.00View SEC Filing  
3/5/2015Barry J AlperinDirectorSell6,637$140.64$933,427.68View SEC Filing  
2/24/2015Stanley KomaroffInsiderSell8,000$141.69$1,133,520.00View SEC Filing  
2/12/2015Donald J KabatDirectorSell5,000$142.68$713,400.00View SEC Filing  
2/12/2015Gerald A BenjaminEVPSell22,116$142.71$3,156,174.36View SEC Filing  
2/12/2015Robert MinowitzInsiderSell11,254$142.63$1,605,158.02View SEC Filing  
12/18/2014Leonard A DavidSVPSell3,557$135.34$481,404.38View SEC Filing  
12/9/2014Stanley M BergmanCEOSell69,600$135.56$9,434,976.00View SEC Filing  
12/8/2014Stanley M BergmanCEOSell23,485$136.34$3,201,944.90View SEC Filing  
11/24/2014Stanley KomaroffInsiderSell13,757$133.06$1,830,506.42View SEC Filing  
11/7/2014Lorelei McglynnSVPSell15,746$129.03$2,031,706.38View SEC Filing  
11/7/2014Mark E MlotekEVPSell6,262$128.75$806,232.50View SEC Filing  
9/2/2014Philip A LaskawyDirectorSell15,438$119.40$1,843,297.20View SEC Filing  
8/29/2014Louis W SullivanDirectorSell17,262$119.99$2,071,267.38View SEC Filing  
6/9/2014Barry J AlperinDirectorSell7,500$120.39$902,925.00View SEC Filing  
6/2/2014Gerald A BenjaminEVPSell12,354$119.50$1,476,303.00View SEC Filing  
5/28/2014Norman S MatthewsDirectorSell6,637$118.68$787,679.16View SEC Filing  
5/19/2014Donald KabatDirectorSell5,000$116.30$581,500.008,851View SEC Filing  
5/15/2014Paul BronsDirectorSell5,363$113.77$610,148.5113,851View SEC Filing  
3/19/2014Barry AlperinDirectorSell7,500$119.18$893,850.0025,104View SEC Filing  
3/17/2014Lonnie ShoffCEOSell3,722$119.06$443,141.3231,267View SEC Filing  
3/12/2014Michael EttingerSVPSell3,537$119.20$421,610.4031,760View SEC Filing  
3/11/2014David MckinleyInsiderSell2,387$119.65$285,604.5528,526View SEC Filing  
3/11/2014James BreslawskiCEOSell72,642$119.35$8,669,822.70113,936View SEC Filing  
3/11/2014Paul RoseSVPSell3,783$119.72$452,900.7620,229View SEC Filing  
3/10/2014Robert MinowitzInsiderSell11,553$119.98$1,386,128.9427,756View SEC Filing  
3/4/2014Donald KabatDirectorSell5,000$119.15$595,750.0012,159View SEC Filing  
2/28/2014Michael RacioppiSVPSell18,614$118.91$2,213,390.7430,667View SEC Filing  
2/26/2014Stanley KomaroffInsiderSell18,000$119.36$2,148,480.0059,796View SEC Filing  
2/25/2014Mark MlotekEVPSell20,333$119.16$2,422,880.2852,899View SEC Filing  
2/20/2014Steven PaladinoCFOSell28,757$117.79$3,387,287.0388,276View SEC Filing  
2/12/2014Philip LaskawyDirectorSell5,851$114.91$672,338.4115,982View SEC Filing  
12/19/2013Mark MlotekEVPSell22,004$111.97$2,463,787.8853,454View SEC Filing  
12/19/2013Michael RacioppiSVPSell29,257$111.97$3,275,906.2926,036View SEC Filing  
12/17/2013Gerald BenjaminEVPSell41,664$111.66$4,652,202.2466,887View SEC Filing  
12/17/2013James BreslawskiCEOSell57,754$111.91$6,463,250.14118,030View SEC Filing  
12/16/2013Steven PaladinoCFOSell47,652$112.31$5,351,796.1288,276View SEC Filing  
12/13/2013Stanley BergmanCEOSell78,000$111.90$8,728,200.00163,770View SEC Filing  
12/6/2013Leonard DavidSVPSell13,968$113.14$1,580,339.5220,620View SEC Filing  
11/26/2013Stanley KomaroffInsiderSell22,329$114.79$2,563,145.9159,796View SEC Filing  
8/23/2013Philip LaskawyDirectorSell21,637$103.17$2,232,289.2921,833View SEC Filing  
8/22/2013Norman MatthewsDirectorSell9,851$103.95$1,024,011.4521,782View SEC Filing  
8/20/2013Louis SullivanDirectorSell15,000$103.91$1,558,650.0020,987View SEC Filing  
8/12/2013Donald KabatDirectorSell2,500$106.25$265,625.0010,598View SEC Filing  
6/18/2013Barry J AlperinDirectorSell7,500$97.74$733,050.00View SEC Filing  
5/8/2013James A HardingCTOSell12,000$92.64$1,111,680.00View SEC Filing  
3/8/2013Donald J KabatDirectorSell4,038$90.00$363,420.00View SEC Filing  
12/4/2012Donald J KabatDirectorSell15,000$80.04$1,200,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Henry Schein (NASDAQ HSIC) News Headlines

Source:
DateHeadline
Henry Schein, Inc. (HSIC) Receives Average Recommendation of "Hold" from BrokeragesHenry Schein, Inc. (HSIC) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - January 19 at 3:58 AM
Henry Schein, Inc. (HSIC) Expected to Announce Quarterly Sales of $3.31 BillionHenry Schein, Inc. (HSIC) Expected to Announce Quarterly Sales of $3.31 Billion
www.americanbankingnews.com - January 18 at 8:38 AM
Henry Schein, Inc. (HSIC) Expected to Post Earnings of $0.97 Per ShareHenry Schein, Inc. (HSIC) Expected to Post Earnings of $0.97 Per Share
www.americanbankingnews.com - January 16 at 9:30 AM
Henry Schein (HSIC) Buys ABASE, Expands in Animal HealthHenry Schein (HSIC) Buys ABASE, Expands in Animal Health
finance.yahoo.com - January 15 at 11:06 AM
William Blair Weighs in on Henry Schein, Inc.s Q1 2018 Earnings (HSIC)William Blair Weighs in on Henry Schein, Inc.'s Q1 2018 Earnings (HSIC)
www.americanbankingnews.com - January 15 at 5:02 AM
Henry Schein, Inc. (HSIC) to Post Q3 2018 Earnings of $1.14 Per Share, William Blair ForecastsHenry Schein, Inc. (HSIC) to Post Q3 2018 Earnings of $1.14 Per Share, William Blair Forecasts
www.americanbankingnews.com - January 12 at 1:42 PM
Wired News – Henry Schein Buys Controlling Stake in Brazil’s Veterinary Health Care Products Distributor ABASEWired News – Henry Schein Buys Controlling Stake in Brazil’s Veterinary Health Care Products Distributor ABASE
finance.yahoo.com - January 10 at 11:29 AM
Henry Schein (HSIC) Acquires Majority Interest In ABASE - StreetInsider.comHenry Schein (HSIC) Acquires Majority Interest In ABASE - StreetInsider.com
www.streetinsider.com - January 9 at 11:09 AM
Henry Schein Buys 60% Stake In ABASE - Quick FactsHenry Schein Buys 60% Stake In ABASE - Quick Facts
www.nasdaq.com - January 8 at 3:45 PM
Henry Schein Acquires Majority Interest In ABASE, A Distributor Of Veterinary Health Care Products In Sao Paulo, BrazilHenry Schein Acquires Majority Interest In ABASE, A Distributor Of Veterinary Health Care Products In Sao Paulo, Brazil
finance.yahoo.com - January 8 at 8:36 AM
Henry Schein (HSIC) Raised to Hold at Zacks Investment ResearchHenry Schein (HSIC) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - January 7 at 8:50 PM
Henry Schein (HSIC) Receives New Coverage from Analysts at Evercore ISIHenry Schein (HSIC) Receives New Coverage from Analysts at Evercore ISI
www.americanbankingnews.com - January 4 at 5:04 PM
ETFs with exposure to Henry Schein, Inc. : January 2, 2018ETFs with exposure to Henry Schein, Inc. : January 2, 2018
finance.yahoo.com - January 2 at 3:58 PM
Henry Schein, Inc. (HSIC) Expected to Post Quarterly Sales of $3.31 BillionHenry Schein, Inc. (HSIC) Expected to Post Quarterly Sales of $3.31 Billion
www.americanbankingnews.com - January 1 at 2:12 PM
Investors Buy High Volume of Henry Schein Put Options (HSIC)Investors Buy High Volume of Henry Schein Put Options (HSIC)
www.americanbankingnews.com - December 31 at 4:22 AM
 Analysts Expect Henry Schein, Inc. (HSIC) Will Post Earnings of $0.97 Per Share Analysts Expect Henry Schein, Inc. (HSIC) Will Post Earnings of $0.97 Per Share
www.americanbankingnews.com - December 30 at 1:18 PM
Piper Jaffray Companies Reiterates "Buy" Rating for Henry Schein (HSIC)Piper Jaffray Companies Reiterates "Buy" Rating for Henry Schein (HSIC)
www.americanbankingnews.com - December 27 at 3:16 PM
Act-On Powers the Billion Dollar Publicly Traded EnterpriseAct-On Powers the Billion Dollar Publicly Traded Enterprise
www.businesswire.com - December 27 at 12:56 PM
Act-On signs on a pair of publicly traded billion-dollar clientsAct-On signs on a pair of publicly traded billion-dollar clients
finance.yahoo.com - December 27 at 12:56 PM
Henry Schein, Inc. (HSIC) Given Consensus Recommendation of "Hold" by BrokeragesHenry Schein, Inc. (HSIC) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 25 at 3:57 AM
ETFs with exposure to Henry Schein, Inc. : December 22, 2017ETFs with exposure to Henry Schein, Inc. : December 22, 2017
finance.yahoo.com - December 22 at 4:45 PM
Henry Schein (HSIC) Acquires eVetPractice - StreetInsider.comHenry Schein (HSIC) Acquires eVetPractice - StreetInsider.com
www.streetinsider.com - December 20 at 3:39 PM
Henry Schein To Present At The 36th Annual J.P. Morgan Healthcare ConferenceHenry Schein To Present At The 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 20 at 11:25 AM
Henry Schein Buys eVetPractice, Boosts Technology & VAS ArmHenry Schein Buys eVetPractice, Boosts Technology & VAS Arm
finance.yahoo.com - December 19 at 11:22 AM
Henry Schein buys vet practice management software providerHenry Schein buys vet practice management software provider
seekingalpha.com - December 18 at 6:19 PM
Henry Schein Acquires EVetPractice; Terms Not Disclosed - Quick FactsHenry Schein Acquires EVetPractice; Terms Not Disclosed - Quick Facts
www.nasdaq.com - December 18 at 11:54 AM
Henry Schein Acquires eVetPractice, A Cloud-Based Veterinary Clinic Practice Management Solutions CompanyHenry Schein Acquires eVetPractice, A Cloud-Based Veterinary Clinic Practice Management Solutions Company
finance.yahoo.com - December 18 at 11:54 AM
$3.31 Billion in Sales Expected for Henry Schein, Inc. (HSIC) This Quarter$3.31 Billion in Sales Expected for Henry Schein, Inc. (HSIC) This Quarter
www.americanbankingnews.com - December 15 at 2:30 PM
Services Stocks Research Reports Released on Quotient Technology, Henry Schein, Patterson, and Owens & Minor - PR Newswire (press release)Services Stocks' Research Reports Released on Quotient Technology, Henry Schein, Patterson, and Owens & Minor - PR Newswire (press release)
www.prnewswire.com - December 15 at 11:53 AM
Henry Schein Celebrates The Season With Its 19th Annual Holiday Cheer For Children Program - PR Newswire (press release)Henry Schein Celebrates The Season With Its 19th Annual Holiday Cheer For Children Program - PR Newswire (press release)
www.prnewswire.com - December 15 at 11:53 AM
ETFs with exposure to Henry Schein, Inc. : December 11, 2017ETFs with exposure to Henry Schein, Inc. : December 11, 2017
finance.yahoo.com - December 11 at 3:38 PM
Henry Schein (HSIC) Research Coverage Started at Deutsche BankHenry Schein (HSIC) Research Coverage Started at Deutsche Bank
www.americanbankingnews.com - December 8 at 11:12 PM
Henry Schein, Patterson Companies Downgraded On Amazon Fears - BenzingaHenry Schein, Patterson Companies Downgraded On Amazon Fears - Benzinga
www.benzinga.com - December 8 at 11:37 AM
Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Southern California Wildfires - PR Newswire (press release)Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Southern California Wildfires - PR Newswire (press release)
www.prnewswire.com - December 8 at 11:37 AM
Amazons Crushing Schein and Patterson on New Dental BusinessAmazon's Crushing Schein and Patterson on New Dental Business
www.thestreet.com - December 6 at 3:40 PM
Cramer says the Amazon 'Death Star' is aimed at dental de...Cramer says the Amazon 'Death Star' is aimed at dental de...
finance.yahoo.com - December 6 at 3:40 PM
Shares of dental suppliers drop on potential new threat from AmazonShares of dental suppliers drop on potential new threat from Amazon
finance.yahoo.com - December 6 at 3:40 PM
Henry Schein (HSIC) Downgraded to Underweight at Morgan StanleyHenry Schein (HSIC) Downgraded to Underweight at Morgan Stanley
www.americanbankingnews.com - December 6 at 9:38 AM
Market Trends Toward New Normal in Henry Schein, Restoration Hardware, GrubHub, Commerce BancsharesMarket Trends Toward New Normal in Henry Schein, Restoration Hardware, GrubHub, Commerce Bancshares
www.nasdaq.com - December 6 at 8:48 AM
Henry Schein, Inc. (HSIC) Director Barry J. Alperin Sells 5,796 SharesHenry Schein, Inc. (HSIC) Director Barry J. Alperin Sells 5,796 Shares
www.americanbankingnews.com - December 4 at 6:12 PM
Henry Schein CEO says extra capital from tax reform will ...Henry Schein CEO says extra capital from tax reform will ...
finance.yahoo.com - December 2 at 8:00 AM
Cramer Remix: Bitcoin has taken away the luster of goldCramer Remix: Bitcoin has taken away the luster of gold
finance.yahoo.com - December 2 at 8:00 AM
Henry Schein, Inc. (HSIC) Receives Consensus Recommendation of "Hold" from AnalystsHenry Schein, Inc. (HSIC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 30 at 3:38 AM
ETFs with exposure to Henry Schein, Inc. : November 29, 2017ETFs with exposure to Henry Schein, Inc. : November 29, 2017
finance.yahoo.com - November 29 at 3:40 PM
Henry Schein, Inc. :HSIC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 28, 2017Henry Schein, Inc. :HSIC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 28, 2017
finance.yahoo.com - November 28 at 3:38 PM
Benzingas Top Upgrades, Downgrades For November 28, 2017 - BenzingaBenzinga's Top Upgrades, Downgrades For November 28, 2017 - Benzinga
www.benzinga.com - November 28 at 9:26 AM
Henry Schein Now Inexpensive After 20% Drop - Seeking AlphaHenry Schein Now Inexpensive After 20% Drop - Seeking Alpha
seekingalpha.com - November 28 at 9:26 AM
Credit Suisse Group Reiterates "Neutral" Rating for Henry Schein, Inc. (HSIC)Credit Suisse Group Reiterates "Neutral" Rating for Henry Schein, Inc. (HSIC)
www.americanbankingnews.com - November 28 at 8:36 AM
Henry Schein, Inc. (HSIC) Coverage Initiated at StephensHenry Schein, Inc. (HSIC) Coverage Initiated at Stephens
www.americanbankingnews.com - November 28 at 7:42 AM
Rising Costs Hurt Henry Schein, End-Market Trends a TailwindRising Costs Hurt Henry Schein, End-Market Trends a Tailwind
finance.yahoo.com - November 22 at 8:53 PM

SEC Filings

Henry Schein (NASDAQ:HSIC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Henry Schein (NASDAQ:HSIC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Henry Schein (NASDAQ HSIC) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.